How much peritoneal dialysis does your patient need? Parameters and goals

Dialysis and Transplantation

Volumn 39, Issue 8, 2010, Pages 344-348

  Teitelbaum, Isaac ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERITONEAL DIALYSIS FLUID;

CARDIOVASCULAR RISK; HUMAN; INFLAMMATION; KIDNEY FAILURE; MINERAL METABOLISM; MORTALITY; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; ULTRAFILTRATION;

EID: 77956902009     PISSN: 00902934     EISSN: 19326920     Source Type: Journal    
DOI: 10.1002/dat.20473     Document Type: Review

References (39)

1. Maiorca R, Brunori G, Zubani R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant. 1995;10(12):2295-2305.
2. Churchill DN, Taylor DW. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7(2):198-207.
3. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA Study. J Am Soc Nephrol. 2001;12(10): 2158-2162.
4. Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307-1320.
5. Lo WK, Ho YW, Li CS, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003;64(2):649-656.
6. Brown EA, Davies SJ, Rutherford P, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol. 2003;14(11):2948-2957.
7. Jansen MA, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT; NECOSAD Study Group. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int. 2005;68(3):1199-1205.
8. Lo WK, Bargman JM, Burkart J, et al; ISPD Adequacy of Peritoneal Dialysis Working Group. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006;26(5):520-522.
9. Fried L, Hebah N, Finkelstein F, Piraino B. Association of Kt/V and creatinine clearance with outcomes in anuric peritoneal dialysis patients. Am J Kidney Dis. 2008;52(6):1122-1130.
10. Plum J, Schoenicke G, Kleophas W, et al. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transpl. 2001;16:2378-2385.
11. Gunal AI, Duman S, Ozkahya M, et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001;37:588-593.
12. Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int. 2003;23:46-52.
13. Jager KJ, Merkus MP, Dedder FW, et al. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Coopertative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int. 1999;55:1476-1485.
14. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis. 2000;35:69-79.
15. Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK. The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transpl. 2005;20:1693-1701.
16. Ates K, Nergizoǧlu G, Keven K, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001;60(2):767-776.
17. Wang AY, Lam CW, Yu CM, et al. N-terminal probrain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol. 2007;18(1):321-330.
18. Paniagua R, Amato D, Mujais S, et al. Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial. Clin J Am Soc Nephrol. 2008;3(2):407-415.
19. Van Olden RW, Guchelaar HJ, Struijk DG, Krediet RT, Arisz L. Acute effects of high-dose furosemide on residual renal function in CAPD patients. Perit Dial Int. 2003;23:339-347.
20. Termorshuizen F, Korevaar JC, Dekker FW, et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 2003;41:1293-1302.
21. Liao CT, Chen YM, Shiao CC, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transpl. 2009;24:2909-2914.
22. Chung SH, Heimbürger O, Stenvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int. 2003;23(2):174-183.
23. Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schulze M, Koch KM. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit Dial Int. 1996;16(2):158-162.
24. Wang AY, Woo J, Lam CW, et al. Is a single time point C-reactive protein predicitive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003;14(7):187-1879.
25. Stenvinkel P, Chung SH, Heimburger O, Lindholm B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int. 2001;21(suppl 3):S157-S162.
26. Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and cacification markers. Nephrol Dial Transpl. 2009;24:3826-3833.
27. Arikan H, Koc M, Tuglular S, Ozener C, Akoglu E. Elevated plasma leves of PAI-1 predict cardiovascular events and cardiovascular mortality in prevalent peritoneal dialysis patients. Ren Fail. 2009;31:438-445.
28. Huber K, Christ G, Wojta J, Gulba D. Plaminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. Thromb Res. 2001;103(suppl 1):S7-S19.
29. Hamsten A, de Faire U, Walldius G, Dahlen G, Sxamosi A, Landou C, Blomback M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3-9.
30. Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation. 1996;94:2057-2063.
31. Young GA, Kopple JD, Lindholm B, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis. 1991;17(4):462-471.
32. Lo WK, Tong KL, Li CS, et al. Relationship between adequacy of dialysis and nutritional status, and their impact on patient survival on CAPD in Hong Kong. Perit Dial Int. 2001;21(5):441-447.
33. Avram MM, Fein PA, Rafiq MA, Schloth T, Chattapadhyay J, Mittman N. Malnutrition and inflammation as predictors of mortality in peritoneal dialysis patients. Kidney Int. 2006;70(S104):S4-7.
34. Prasad N, Gupta A, Sharma RK, Sinha A, Kumar R. Impact of nutritional status on peritonitis in CAPD patients. Perit Dial Int. 2007;27(1):42-47.
35. Chuang YW, Shu KH, Yu TM, Cheng CH, Chen CH. Hypokalemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Neph Dial Transpl. 2009;24:1603-1608.
36. Trivedi H, Tan SH, Prowant B, et al. Predictors of death in patients on peritoneal dialysis: the Missouri Peritoneal Dialysis Study. Am J Nephrol. 2005;25(5):466-473.
37. Noordzij M, Korevaar JC, Bos WJ, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant. 2006;21(9):2513-2520.
38. Mehrotra R, R, Khawar O, Duong E, et al. Serum phosphorus and mortality in chronic peritoneal dialysis (CPD) patients. Perit Dial Int. 2007;27(suppl 3):S12.
39. Khawar O, Mehrotra R, Duong U, et al. Serum calcium and survival in a large USA cohort of chronic peritoneal dialysis patients. Perit Dial Int. 2007;27(suppl 3):S11.